The IL-1Ra-treated mice showed no occurrence of JE or mortality (0/13), whereas the vehicle-treated mice showed severe signs of (Fig. 14A and B) and increased mortality by JE (7/14) (Fig. 14C), suggesting the IL-1α antagonist potently reduced the incidence of JE. The gene discussed is IL1A; the disease is Japanese encephalitis.